Docplanner has acquired Jameda, a German online healthcare marketplace. No financial terms were disclosed. Docplanner’s backers included Point Nine Capital, Goldman Sachs Asset Management and One Peak Partners.
23 November 2021 – Docplanner, the largest online healthcare marketplace in the world and a leading provider of SaaS solutions for doctors and clinics, today announced its acquisition of Munich-based Jameda, Germany’s biggest and most established online healthcare marketplace, from Hubert Burda Media. Jameda partners with about 20,000 doctors and attracts 8 million patients to its platform monthly which will be a significant addition to Docplanner’s existing global client base of 110,000 doctors and nearly 70 million monthly patients.
As part of the acquisition, Docplanner will invest significant capital and global expertise into Jameda and will focus on rapidly growing the company’s sales, customer care and marketing teams. Docplanner has big ambitions for Germany and will add more than 200 new team members to Jameda, investing more than a quarter of a billion euros in the German market over the next 2 to 3 years. Docplanner also expects to deliver even better solutions to the market from combining the best elements of both companies’ products.
The acquisition marks Docplanner’s first meaningful entry into a new geography since 2017 when it opened up local operations in Mexico and Brazil. The company also has leading market positions in Italy, Spain, Turkey and in its home market, Poland, giving it the broadest geographic reach in the digital healthcare space globally. Post-acquisition, Docplanner will be active in markets which generate more than 50% of all healthcare expenditures made in Europe and 84% of those made in Latin America.
Docplanner founder and CEO, Mariusz Gralewski, said: “Docplanner was founded on the mission of making the healthcare experience more human. We view this as the perfect opportunity to enter the very important German market and positively impact the healthcare ecosystem. We are confident that the Jameda team has both unparalleled experience and the drive to win the market. We are super excited to work with the Jameda team in the years ahead and build even more amazing products for patients and doctors in Germany.”
Dr Florian Weiss, CEO at Jameda, said: “Docplanner is the perfect match for Jameda, since we share much of the same heritage and history. Jameda strongly believes in the importance of trustful relationships between doctors and patients, and we are committed to leveraging innovative digital solutions to foster these relationships. Making healthcare more human has always been at the heart of what we do and the partnership with Docplanner will help to turn that vision into reality more rapidly and in a more powerful way.”
The acquisition of Jameda, which will be fully effective from 1 January 2022, is the next step in Docplanner’s growth strategy. The company has demonstrated strong organic performance combined with a history of successful acquisitions as part of its global expansion efforts. It has made six other acquisitions to date, including TuoTempo in Italy (2019), Doctoralia in Spain (2016) and Eniyihekim (now Doktortakvimi) in Turkey (2014).
With a global mission to “make the healthcare experience more human”, Docplanner creates digital apps and software solutions for doctors, clinics, hospitals and patients to enable the healthcare ecosystem and the patient journey to work together more seamlessly. With free doctor reviews and instant online appointment booking for patients through its online marketplaces, Docplanner has a network of almost 2 million healthcare professionals, serves over 100,000 customers globally and operates in more than 12 countries. Doctors and clinics count on Docplanner to facilitate scheduling, booking, communication and payments for millions of patients a month. Through its innovative and user-friendly software, doctors and clinics can optimize patient flow, reduce costly no-shows and completely digitize their practices – all resulting in valuable time savings that can instead be used to improve patient outcomes and experiences. Via its TuoTempo brand, the company offers a more sophisticated suite of optimisation products for large healthcare institutions. Docplanner was founded in 2012 in Poland and now boasts a team of more than 1,800 based across offices in Warsaw, Barcelona, Istanbul, Rome, Mexico City, Curitiba and Bologna. It is backed by leading venture capital funds including Point Nine Capital, Goldman Sachs Asset Management and One Peak Partners, raising a total of approximately €300 million to date.
For more information, visit: https://www.docplanner.com/about-us